Justification

  It will drastically drop the incidence of HPV infections which will in turn reduce the incidence of cervical cancer, and gradually build a community in which every girl/ lady/ woman would be immune to cervical cancer.

  The type of HPV to be used is the cervarix vaccine. This is because of its relative economic advantage.

Problem to be addressed

  According to a study carried out by Akinfenwa A.T. and Monsur T.A., it was discovered that the burden of cervical cancer in the Northern part of Nigeria is associated with age-standardized incidence and mortality rates of 36 in 100,000 and 17.5 in 100,000 respectively. This shows that almost 50% of everyone diagnosed with cervical cancer ends up dying.

  Also there is a younger mean age of occurrence among Nigerian women- 4th decade of life. Coupled with various cultural and religious practices and the fact that the number of educated women in the Northern part of the country is heartbreakingly low, cervical cancer has transformed from being just a menace to a real monster.

References

Citation

Citation: Tolulope Ajayi. “Prevention of HPV Infection and Cervical Cancer. The Role of the HPV Vaccine in Kano State, Nigeria”.Acta Scientific Cancer Biology 4.3 (2020): 37-38.

Copyright

Copyright: © 2020 Tolulope Ajayi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.